JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
BBIO Financials - Bridgebio Pharma Income & Cash Flow | Ledgeburg
BBIO - Bridgebio Pharma, Inc.
USD | NASDAQ | Healthcare
Summary
Summary BBIO Stock
Financials
Financials BBIO Stock
Loading...
Loading...
Income Statement
Income Statement BBIO Stock
Balance Sheet
Balance Sheet BBIO Stock
Cash Flow Statement
Cash Flow Statement BBIO Stock
Loading...
Loading...
Home
Stocks
Bridgebio Pharma, Inc. (BBIO)
Financials
Financials of BBIO
Loading...
Loading...
Loading...
Loading...
Revenue
$502.076M
Operating Income
$-523.411M
Net Income
$-732.938M
Share Count (Basic)
191.527482M
Operating Cash Flow
$-445.91M
Free Cash Flow
$-447.007M
Cash And Short-Term Equivalents
$570.119M
Total Debt
$2.007337B
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
500M
FY2021
FY2022
FY2023
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-700M
-650M
-600M
-550M
-500M
Annual
Quarterly
Margins
Gross
Operating
Net
-8000%
-6000%
-4000%
-2000%
0%
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-190M
-180M
-170M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-150%
-100%
-50%
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26